Latest articles

Ten projects from across EMEA have been announced as ULI Europe Awards for Excellence finalists, with life sciences claiming three spots.

France and Ireland lead the €5–10 million bracket, largely concentrated in point of care and R&D assets across Europe.

Converting former science facilities to new uses offers investors portfolio protection against tenant risk while unlocking new income streams.

Life sciences real estate offers institutional investors resilient returns, portfolio diversification, and alignment with healthcare megatrends.

Over €200 billion has flowed into European life sciences start-ups and scale-ups over the past decade. This funding is powering innovation and reshaping the sector's real estate.

Europe's energy-intensive labs are pioneering ESG solutions, from London's intelligent building systems to Copenhagen's low-carbon retrofits.